RWM
TNYA icon

Rialto Wealth Management’s Tenaya Therapeutics TNYA Stock Holding History

Rialto Wealth Management’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$675 Buy
+913
New +$693 ﹤0.01% 1521
2025
Q2 		– Sell
-833
Closed -$475 – 1762
2025
Q1 		$475 Buy
+833
New +$822 ﹤0.01% 904

Other funds holding TNYA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.77B AUM 65.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Rialto Wealth Management's TNYA Position: Q2 2026 in Review

Rialto Wealth Management opened a new position in Tenaya Therapeutics (TNYA) in Q2 2026: 913 shares worth $675. The stake represents ﹤0.01% of the portfolio and ranks #1521 among its holdings. This is a return to the name: Rialto Wealth Management previously reported a position in TNYA as recently as Q1 2025.

Rialto Wealth Management first reported a position in TNYA in Q1 2025 and has held it in 2 quarters since. 101 funds tracked by Wall St. Rank hold TNYA as of Q2 2026.

  • Rialto Wealth Management held 913 shares of Tenaya Therapeutics worth $675 as of Q2 2026.
  • Tenaya Therapeutics was a new Rialto Wealth Management position in Q2 2026.
  • Tenaya Therapeutics made up ﹤0.01% of Rialto Wealth Management's portfolio in Q2 2026, its #1521 holding.
  • Rialto Wealth Management first reported a position in Tenaya Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • 101 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2026.

Based on Rialto Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.